OPTIMI HEALTH Corp. Registered Shares o.N.
- BID
3.905
- ASK
4.045
- 512 Units494 Units
- 07/22, 21:59:58 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
39.43%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.75 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 3.89 G | 0 Units |
| PRICE DETERMINATION TIME | 07/22/2026 / 09:57:01 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 4.09 | 3.89 |
| PREV. DAY'S PRICE | 4.045 | (07/21) |
| CHANGE DAY BEFORE | -0.15 | -3.83 % |
| 52 WEEK HIGH / LOW | 7.86 (02/16) | 0.212 (05/20) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -1.25 | -1.37 | -0.75 | - | - |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | - | - |
PRICE - BOOK RATIO | 1.22 | 2.37 | 5.66 | - | - |
PRICE - SALES RATIO | 88.86 | 55.12 | 86.69 | - | - |
PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A411WC |
| ISIN | CA68405H3080 |
| SYMBOL | 8BN0 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | OPTIMI HEALTH CORP. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 9.58 % | -7.60 % | -39.97 % | -33.16 % | 39.43 % | -0.26 % | -72.47 % | -34.18 % |
| HIGH | 4.41 | 4.56 | 7.26 | 7.86 | 7.86 | 10.08 | 14.85 | 7.86 |
| LOW | 3.89 | 3.47 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 |
Dividende
pro Aktie
OPTIMI HEALTH CORP. does not deliver dividend information
Company profile
Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. It offers formulation, active pharmaceutical ingredients (APIs), and drug product manufacturing from preclinical stages to analysis and commercial distribution and It also offers botanical psilocybin and MDMA. The company was founded on May 27, 2020 and is headquartered in Squamish, Canada.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.